Principal Investigator: Shailesh Gupta, MD

  • Evaluating the duration of effect of a certain medication in participants with open-angle glaucoma or ocular hypertension
  • Ophthalmic solutions for the treatment of dry eye
  • Use of medications in subjects with open-angle glaucoma or ocular hypertension
  • An extension trial to evaluate medications in patients with open angle glaucoma or ocular hypertension
  • Using a micro-bypass stent system in conjunction with cataract surgery
  • Comparing two models of an intraocular implant to an ophthalmic solution
  • Gel stent versus trabeculectomy in open-angle glaucoma
  • Study to evaluate a medication twice daily compared with vehicle for the treatment of inflammation and pain associated with ocular surgery
  • Use of a surgical system in combination with cataract extraction in open angle glaucoma
  • Once daily versus three times daily ophthalmic suspension in subjects with open angle glaucoma, or ocular hypertension
  • Orally administered medication study on subjects with non-proliferative diabetic retinopathy without center-involved Diabetic Macular Edema
  • A phase 2b multicenter dose-ranging study comparing 2 medications in subjects with neovascular (wet) age-related macular degeneration
  • A study evaluating an ophthalmic solution compared to placebo in subjects with dry eye

Dr. Shailesh Gupta

Dr. Gupta is a board certified ophthalmologist who is a Floridian through and through. He attained his medical doctorate from the University of Miami School of Medicine. Followed by residency and fellowship at the University of Florida, where he is currently an assistant professor and the director of vitreo-retinal fellowship. Dr Gupta has been a practicing physician since 1997 and has been diligently working as a Principal Investigator in research for the past seven years. He has written several dozen publications and has been a member of the Association for Research in Vision and Ophthalmology for over 20 years.

Principal Investigator: Sirtaz Sibia, DO

  • Ophthalmic solution use for the treatment of dry eye
  • Ophthalmic solution compared to placebo in subjects with dry eye

Dr. Sirtaz Sibia

Dr. Sibia obtained his Doctor of Osteopathic Medicine from Nova Southeastern University in 1995 and was on the Dean’s List. He then went to Michigan State University for residency and became Chief Resident while concurrently being a faculty appointed clinical instructor. He is currently a member of the American Osteopathic Association, the American Academy of Ophthalmology as well as the American Osteopathic Colleges of Ophthalmology and Otolaryngology, Head and Neck Surgery. He has made over a dozen scientific presentations and has completed several specialty courses including LASIK and facelift/endoscopic brow lift. He has been a Principal Investigator on various studies since 2013.